HBK Sorce Advisory LLC raised its position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 14.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,194 shares of the company’s stock after buying an additional 1,057 shares during the quarter. HBK Sorce Advisory LLC’s holdings in BlackRock Health Sciences Trust were worth $311,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of BME. Hara Capital LLC bought a new position in shares of BlackRock Health Sciences Trust during the fourth quarter valued at approximately $832,000. AlphaStar Capital Management LLC bought a new position in shares of BlackRock Health Sciences Trust during the fourth quarter valued at approximately $878,000. Janney Montgomery Scott LLC grew its holdings in shares of BlackRock Health Sciences Trust by 40.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock valued at $1,244,000 after purchasing an additional 9,455 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of BlackRock Health Sciences Trust during the fourth quarter valued at approximately $3,250,000. Finally, Wolverine Asset Management LLC grew its holdings in shares of BlackRock Health Sciences Trust by 29.1% during the fourth quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock valued at $4,191,000 after purchasing an additional 24,928 shares during the last quarter.
BlackRock Health Sciences Trust Stock Down 0.1 %
NYSE:BME opened at $38.38 on Friday. The stock has a 50 day moving average of $39.90 and a 200-day moving average of $40.22. BlackRock Health Sciences Trust has a 52 week low of $36.87 and a 52 week high of $42.64.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Read More
- Five stocks we like better than BlackRock Health Sciences Trust
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Why Invest in High-Yield Dividend Stocks?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Are the U.K. Market Holidays? How to Invest and Trade
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.